A hospital based study on the surgical outcomes of thyroid malignancies

R. Anuj Srinivasan, K. Rajachidambaram, Karthick P., M. Vijay Anand


Background: Thyroid cancer is a heterogeneous disease that affects all age groups. The tumors are found to be more aggressive in the elderly. The distribution of these cancers in India continues to remain uncertain. The impact of geographic locations in the incidence of thyroid malignancies is yet to be explored. This study was done to estimate the prevalence and distribution of thyroid cancers.

Methods: This hospital based retrospective study was done at the Department of Surgery of our medical college hospital. About 50 medical records of patients diagnosed with thyroid cancers at our hospital were analyzed. Data on clinical examination, ultrasound findings and histopathology findings were documented.

Results: Out of the 50 patients studied 16 patients had dysphagia, eight patients had dyspnoea and 24 patients had regional metastasis. The most common surgery done for the primary cancer is total thyroidectomy. Hemithyroidectomy was done in 10 patients with SNG, out of which one patient had discrete lymph node per operatively and node dissection was carried out.

Conclusions: TSH suppressive doses are recommended for all patients with papillary and follicular thyroid cancers. A cohort study to analyze the survival outcomes of the patients treated with both the surgical modalities will give an insight into the management of thyroid malignancies.


Papillary carcinoma, Neck dissection, Thyroidectomy, Multinodular goiter

Full Text:



Stewart BW, Wild CP. World cancer report 2014. Lyon: International Agency for Research on Cancer; 2014.

Wartofsky L. Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure? Hormones (Athens). 2010;9:103–8.

Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic": screening and overdiagnosis. N Engl J Med. 2014;371:1765–7.

Atlanta, GA: American Cancer Society; 2015. What are the risk factors for thyroid cancer? Available at: Accessed on 1st May 2016.

Schmid D, Behrens G, Jochem C, Keimling M, Leitzmann M. Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis. Eur J Epidemiol. 2013;28:945–58.

Zhao ZG, Guo XG, Ba CX, Wang W, Yang YY, Wang J, et al. Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Int Med Res. 2012;40:2041–50.

Kitahara CM, Linet MS, Beane Freeman LE, Check DP, Church TR, Park Y, et al. Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes Control. 2012;23:1615–24.

Cho YA, Kim J. Thyroid cancer risk and smoking status: a meta-analysis. Cancer Causes Control. 2014;25:1187–95.

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. Lyon: International Agency for Research on Cancer; 2013. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Available at: Accessed on 1st May 2016.

Allison PD. Survival analysis using the SAS: a practical guide. Cary, NC: SAS Institute Inc.; 1995.

Lyon: International Agency for Research on Cancer; 2013. Thyroid: ASR (W) per 100,000, all ages. Available at: Accessed on 1st May 2016.

Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat. 2015;47:127-41.

Farahati J, Bucsky P, Parlowsky T, Mader U, Reiners C. Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology. Cancer. 1997;80:2156-62.

Rossing MA, Voigt LF, Wicklund KG, Daling JR. Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol. 2000;151:765–72.

Horn-Ross PL, Canchola AJ, Ma H, Reynolds P, Bernstein L. Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort. Cancer Epidemiol Biomarkers Prev. 2011;20:1751–9.

Zeng Q, Chen GG, Vlantis AC, van Hasselt CA. Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Prolif. 2007;40:921-35.

Kumar A, Klinge CM, Goldstein RE. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. Int J Oncol. 2010;36:1067–80.

Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab. 2001;86:1072-7.